SCHEMBL21020263

SCHEMBL21020263

CN(c1ccc(OC(F)(F)F)cc1)c1cccc2c1oc1ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.39
EPHX2 P34913 2/20 0.38
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC6A4 P31645 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
DHFR P00374 1/20 0.34
MAOB P27338 2/20 0.34
CCR6 P51684 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21020448 0.85 ACP1 (0.36) ACP1EPHX2LMNASMN1; SMN2SLC6A4
SCHEMBL20650771 0.85 EPHX2 (0.38) ACP1EPHX2MAPTLMNAMEN1
SCHEMBL21019981 0.85 DHFR (0.37) ACP1EPHX2LMNASMN1; SMN2SLC6A4
SCHEMBL16710482 0.84 EPHX2 (0.38) ACP1EPHX2MAPTLMNAMEN1
SCHEMBL21020297 0.84 ACP1 (0.36) ACP1EPHX2LMNASMN1; SMN2SLC6A4
SCHEMBL21020265 0.83 CYP2C19 (0.40) EPHX2MAPTMEN1KMT2ACYP2C19
SCHEMBL21021485 0.83 ACP1 (0.37) ACP1EPHX2MEN1KMT2ASLC6A4
SCHEMBL21020284 0.83 P2RY1 (0.35) ACP1EPHX2LMNASMN1; SMN2SLC6A4
SCHEMBL20172792 0.82 MAOA (0.39) EPHX2MAPTLMNAMEN1KMT2A
SCHEMBL21020275 0.82 P2RY1 (0.37) ACP1SLC6A4SLC6A3KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ETV6, ESR1 ACP1 4663/4885EPHX2 150/4885MAPT 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.